This chronic skin condition is managed with three pillars: daily tinted sunscreen, topical therapy, and long-term maintenance to prevent relapse.
Melasma is a chronic pigmentation disorder that responds to structured medical management, not quick fixes. The dermatological consensus centers on three treatment pillars that work together: rigorous daily photoprotection, induction therapy to clear existing pigmentation, and long-term maintenance to keep it from returning. Each pillar plays a specific role, and skipping any one of them invites recurrence. Understanding how these pieces fit together is the first step toward real control.
Melasma Treatment: The Three-Pillar Framework
The induction phase uses stronger topical agents for two to four months to reduce visible pigmentation. After that, the maintenance phase shifts to gentler agents paired with strict sun protection. This structured approach recognizes melasma as a chronic condition requiring indefinite care, similar to managing eczema or psoriasis. The table below summarizes the main treatment categories and their practical specifications.
| Therapy Type | First-Line Agents | Key Specifications |
|---|---|---|
| Topical induction | Triple combination cream (4% hydroquinone, 0.05% tretinoin, 0.01% fluocinolone acetonide) | Apply nightly for 2–4 months |
| Topical alternative | Hydroquinone 4% alone | Apply 1–2 times daily, up to 6 months |
| Non-hydroquinone topical | Azelaic acid 20%, kojic acid, vitamin C, thiamidol | Start once daily; increase to twice daily by week 4 |
| Oral therapy | Tranexamic acid 250–500 mg | 1–2 times daily for 3–6 months; requires supervision |
| Non-HQ maintenance | Azelaic acid, thiamidol, vitamin C | Long-term use after induction |
| Photoprotection | Tinted mineral sunscreen with iron oxides, SPF 30–50+ | Apply daily; reapply every 2 hours when outdoors |
| Procedural (second-line) | Q-switched laser, low-fluence laser, IPL, superficial peels | Only after topical stabilization; risk of worsening if used during active stage |
Daily Photoprotection With Tinted Sunscreen
Photoprotection is the foundational pillar. Standard sunscreens block UV rays but miss visible light, which contributes to melasma. Tinted mineral sunscreens containing iron oxides block both UV and visible light, including the blue-violet spectrum emitted by the sun and digital screens. This distinction matters because even indoor exposure to visible light can maintain or worsen pigmentation in people prone to melasma.
Use a broad-spectrum, tinted sunscreen with SPF 30 to 50 or higher every day, year-round, and reapply every two hours when exposed to sunlight. Physical barriers such as wide-brimmed hats and seeking shade between 10 AM and 4 PM add meaningful protection. Avoid unnecessary heat exposure from saunas, hot cooking environments, and direct overhead heat, since heat itself can act as a trigger. A consistent photoprotection routine is the single strongest predictor of whether melasma stays controlled.
Topical and Oral Treatment Options
Topical Induction Therapy
Triple combination cream containing 4% hydroquinone, 0.05% tretinoin, and 0.01% fluocinolone acetonide is the most effective first-line treatment for active melasma, applied nightly for two to four months. Hydroquinone 4% alone is also effective when applied once or twice daily for up to six months. For patients who cannot use hydroquinone, azelaic acid 20%, kojic acid, vitamin C, and thiamidol are reliable alternatives. Starting azelaic acid once daily for the first week and gradually increasing to twice daily by week four helps minimize irritation. As part of a complete skincare routine, choosing a gentle, melasma-safe cleanser supports the skin barrier and reduces the irritation that can accompany topical therapy.
Oral Therapy
Tranexamic acid is the most studied oral agent for melasma. Taken at 250 to 500 mg once or twice daily for three to six months, it reduces pigmentation by inhibiting tyrosinase activity and decreasing the vascular component of melasma. Clinical trials show measurable improvement by twelve weeks, with continued benefit through six months. It requires medical supervision due to potential side effects including gastrointestinal discomfort and, rarely, thromboembolic events. Other oral options such as Polypodium leucotomos and glutathione are less established but appear in some protocols as adjuncts.
Procedural Options
Lasers, intense pulsed light, and chemical peels are second- or third-line treatments reserved for stable melasma that has been controlled with topical therapy first. Performing these procedures during active melasma often worsens pigmentation rather than improving it. When the timing is right, appropriate options include Q-switched lasers, low-fluence lasers, IPL, microneedling, and superficial chemical peels. The key is proper patient selection and a conservative approach to avoid complications.
FAQs
Can melasma be cured completely?
Melasma is a chronic, relapsing condition with no permanent cure. Treatment focuses on controlling visible pigmentation and maintaining results through consistent photoprotection and maintenance therapy. Some dermal pigment may persist even with successful treatment.
Is hydroquinone safe to use at home?
In the United States, hydroquinone at prescription strength (over 2%) is used under medical supervision for defined periods of two to six months. Unsupervised long-term use carries risks including exogenous ochronosis, a permanent darkening of the skin. Maintenance therapy typically shifts to non-hydroquinone agents such as azelaic acid or thiamidol.
What causes melasma to return after treatment?
Sunscreen omission, heat exposure, hormonal changes such as birth control or pregnancy, and visible light from screens and sunlight are the most common triggers for relapse. Consistent photoprotection and trigger management are essential for long-term control.
References & Sources
- StatPearls. “Melasma: Chronic Control.” Comprehensive overview of melasma as a chronic condition requiring indefinite management.
- Journal of the American Academy of Dermatology. “Medical management of melasma: a review.” Detailed review of topical, oral, and procedural treatment protocols with clinical evidence.
- International Journal of Dermatology and Venereology. “Consensus on the diagnosis and treatment of melasma.” Expert consensus on diagnostic criteria, treatment algorithms, and management strategies.
Mo Maruf
I created WellFizz to bridge the gap between vague wellness advice and actionable solutions. My mission is simple: to decode the research and give you practical tools you can actually use.
Beyond the data, I am a passionate traveler. I believe that stepping away from the screen to explore new environments is essential for mental clarity and physical vitality.